nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—Testosterone—Exemestane—breast cancer	0.135	0.591	CrCrCtD
Abiraterone—CYP17A1—breast cancer	0.124	0.38	CbGaD
Abiraterone—ABCC1—breast cancer	0.112	0.344	CbGaD
Abiraterone—Testosterone—Fluoxymesterone—breast cancer	0.0938	0.409	CrCrCtD
Abiraterone—ABCC1—Idarubicin—breast cancer	0.0391	0.14	CbGbCtD
Abiraterone—CYP2D6—breast cancer	0.0346	0.106	CbGaD
Abiraterone—CYP3A4—breast cancer	0.0296	0.0908	CbGaD
Abiraterone—ALB—breast cancer	0.0259	0.0792	CbGaD
Abiraterone—ABCC1—Mitoxantrone—breast cancer	0.0168	0.0601	CbGbCtD
Abiraterone—ABCC1—Epirubicin—breast cancer	0.0136	0.0487	CbGbCtD
Abiraterone—ABCC1—Paclitaxel—breast cancer	0.0134	0.048	CbGbCtD
Abiraterone—ABCC1—Irinotecan—breast cancer	0.0132	0.0473	CbGbCtD
Abiraterone—CYP2C8—Lapatinib—breast cancer	0.0123	0.0439	CbGbCtD
Abiraterone—ABCC1—Vinblastine—breast cancer	0.0118	0.0421	CbGbCtD
Abiraterone—CYP3A4—Exemestane—breast cancer	0.00985	0.0352	CbGbCtD
Abiraterone—ABCC1—Docetaxel—breast cancer	0.00971	0.0347	CbGbCtD
Abiraterone—CYP2C8—Raloxifene—breast cancer	0.00931	0.0333	CbGbCtD
Abiraterone—CYP2D6—Idarubicin—breast cancer	0.0089	0.0318	CbGbCtD
Abiraterone—CYP3A4—Letrozole—breast cancer	0.00838	0.0299	CbGbCtD
Abiraterone—CYP3A4—Anastrozole—breast cancer	0.00747	0.0267	CbGbCtD
Abiraterone—ABCC1—Doxorubicin—breast cancer	0.00724	0.0259	CbGbCtD
Abiraterone—ABCC1—Methotrexate—breast cancer	0.00701	0.0251	CbGbCtD
Abiraterone—CYP3A4—Toremifene—breast cancer	0.00683	0.0244	CbGbCtD
Abiraterone—CYP3A4—Fulvestrant—breast cancer	0.00635	0.0227	CbGbCtD
Abiraterone—CYP2C8—Tamoxifen—breast cancer	0.00615	0.022	CbGbCtD
Abiraterone—ALB—Irinotecan—breast cancer	0.00611	0.0218	CbGbCtD
Abiraterone—ALB—Fluorouracil—breast cancer	0.00587	0.021	CbGbCtD
Abiraterone—CYP3A4—Thiotepa—breast cancer	0.00566	0.0202	CbGbCtD
Abiraterone—CYP3A4—Ixabepilone—breast cancer	0.00518	0.0185	CbGbCtD
Abiraterone—CYP3A4—Lapatinib—breast cancer	0.00498	0.0178	CbGbCtD
Abiraterone—CYP2C8—Paclitaxel—breast cancer	0.00479	0.0171	CbGbCtD
Abiraterone—CYP2C8—Fluorouracil—breast cancer	0.00453	0.0162	CbGbCtD
Abiraterone—CYP2D6—Vinorelbine—breast cancer	0.00435	0.0155	CbGbCtD
Abiraterone—CYP2D6—Tamoxifen—breast cancer	0.00392	0.014	CbGbCtD
Abiraterone—CYP3A4—Raloxifene—breast cancer	0.00378	0.0135	CbGbCtD
Abiraterone—ALB—Methotrexate—breast cancer	0.00323	0.0116	CbGbCtD
Abiraterone—CYP3A4—Vinorelbine—breast cancer	0.00276	0.00987	CbGbCtD
Abiraterone—CYP2D6—Vinblastine—breast cancer	0.00268	0.00957	CbGbCtD
Abiraterone—CYP3A4—Tamoxifen—breast cancer	0.00249	0.00891	CbGbCtD
Abiraterone—CYP3A4—Mitoxantrone—breast cancer	0.00243	0.00869	CbGbCtD
Abiraterone—CYP3A4—Paclitaxel—breast cancer	0.00194	0.00694	CbGbCtD
Abiraterone—CYP3A4—Irinotecan—breast cancer	0.00192	0.00684	CbGbCtD
Abiraterone—CYP3A4—Vinblastine—breast cancer	0.0017	0.00609	CbGbCtD
Abiraterone—CYP2D6—Doxorubicin—breast cancer	0.00165	0.00588	CbGbCtD
Abiraterone—CYP3A4—Docetaxel—breast cancer	0.0014	0.00502	CbGbCtD
Abiraterone—CYP3A4—Doxorubicin—breast cancer	0.00105	0.00374	CbGbCtD
Abiraterone—SULT2A1—female reproductive system—breast cancer	0.000951	0.0802	CbGeAlD
Abiraterone—SULT2A1—adrenal gland—breast cancer	0.000928	0.0783	CbGeAlD
Abiraterone—SULT2A1—female gonad—breast cancer	0.000865	0.073	CbGeAlD
Abiraterone—SULT2A1—endocrine gland—breast cancer	0.000805	0.0679	CbGeAlD
Abiraterone—ALB—mammary gland—breast cancer	0.000616	0.052	CbGeAlD
Abiraterone—SULT2A1—lymph node—breast cancer	0.000556	0.0469	CbGeAlD
Abiraterone—CYP2C8—mammary gland—breast cancer	0.000433	0.0365	CbGeAlD
Abiraterone—ABCC1—nipple—breast cancer	0.000421	0.0355	CbGeAlD
Abiraterone—CYP17A1—female reproductive system—breast cancer	0.000414	0.0349	CbGeAlD
Abiraterone—CYP17A1—adrenal gland—breast cancer	0.000404	0.0341	CbGeAlD
Abiraterone—CYP17A1—female gonad—breast cancer	0.000377	0.0318	CbGeAlD
Abiraterone—ORM1—endometrium—breast cancer	0.000351	0.0296	CbGeAlD
Abiraterone—CYP17A1—endocrine gland—breast cancer	0.00035	0.0295	CbGeAlD
Abiraterone—ORM1—female reproductive system—breast cancer	0.000291	0.0245	CbGeAlD
Abiraterone—ORM1—bone marrow—breast cancer	0.000274	0.0231	CbGeAlD
Abiraterone—ABCC1—endometrium—breast cancer	0.000254	0.0214	CbGeAlD
Abiraterone—ALB—adrenal gland—breast cancer	0.000249	0.021	CbGeAlD
Abiraterone—ORM1—endocrine gland—breast cancer	0.000246	0.0207	CbGeAlD
Abiraterone—CYP17A1—lymph node—breast cancer	0.000242	0.0204	CbGeAlD
Abiraterone—ABCC1—uterus—breast cancer	0.000234	0.0197	CbGeAlD
Abiraterone—ABCC1—pituitary gland—breast cancer	0.00023	0.0194	CbGeAlD
Abiraterone—ABCC1—adipose tissue—breast cancer	0.000229	0.0193	CbGeAlD
Abiraterone—Testosterone—SHBG—breast cancer	0.000216	0.173	CrCbGaD
Abiraterone—Testosterone—CYP1B1—breast cancer	0.000216	0.173	CrCbGaD
Abiraterone—CYP2C8—endometrium—breast cancer	0.000216	0.0182	CbGeAlD
Abiraterone—ABCC1—adrenal gland—breast cancer	0.000205	0.0173	CbGeAlD
Abiraterone—CYP2C8—pituitary gland—breast cancer	0.000196	0.0165	CbGeAlD
Abiraterone—ABCC1—female gonad—breast cancer	0.000191	0.0161	CbGeAlD
Abiraterone—Testosterone—AR—breast cancer	0.00019	0.152	CrCbGaD
Abiraterone—CYP2C8—female reproductive system—breast cancer	0.000179	0.0151	CbGeAlD
Abiraterone—ORM1—lymph node—breast cancer	0.00017	0.0143	CbGeAlD
Abiraterone—Testosterone—CYP19A1—breast cancer	0.000159	0.127	CrCbGaD
Abiraterone—CYP2C8—endocrine gland—breast cancer	0.000152	0.0128	CbGeAlD
Abiraterone—Testosterone—ABCG2—breast cancer	0.000149	0.119	CrCbGaD
Abiraterone—ALB—lymph node—breast cancer	0.000149	0.0126	CbGeAlD
Abiraterone—ABCC1—lymph node—breast cancer	0.000123	0.0104	CbGeAlD
Abiraterone—CYP3A4—female reproductive system—breast cancer	0.000121	0.0102	CbGeAlD
Abiraterone—CYP2D6—female reproductive system—breast cancer	0.000119	0.0101	CbGeAlD
Abiraterone—Testosterone—CYP1A1—breast cancer	0.000117	0.0936	CrCbGaD
Abiraterone—CYP2D6—female gonad—breast cancer	0.000109	0.00916	CbGeAlD
Abiraterone—CYP3A4—endocrine gland—breast cancer	0.000103	0.00866	CbGeAlD
Abiraterone—CYP2D6—endocrine gland—breast cancer	0.000101	0.00852	CbGeAlD
Abiraterone—Testosterone—CYP3A4—breast cancer	7.46e-05	0.0597	CrCbGaD
Abiraterone—Testosterone—ALB—breast cancer	6.51e-05	0.0521	CrCbGaD
Abiraterone—Testosterone—ABCB1—breast cancer	6.21e-05	0.0497	CrCbGaD
Abiraterone—Musculoskeletal discomfort—Gemcitabine—breast cancer	4.75e-05	0.000506	CcSEcCtD
Abiraterone—Angiopathy—Docetaxel—breast cancer	4.72e-05	0.000503	CcSEcCtD
Abiraterone—Vomiting—Melphalan—breast cancer	4.72e-05	0.000503	CcSEcCtD
Abiraterone—Insomnia—Gemcitabine—breast cancer	4.71e-05	0.000502	CcSEcCtD
Abiraterone—Dyspepsia—Mitoxantrone—breast cancer	4.71e-05	0.000502	CcSEcCtD
Abiraterone—Dyspepsia—Irinotecan—breast cancer	4.71e-05	0.000502	CcSEcCtD
Abiraterone—Mediastinal disorder—Docetaxel—breast cancer	4.69e-05	0.0005	CcSEcCtD
Abiraterone—Rash—Melphalan—breast cancer	4.68e-05	0.000499	CcSEcCtD
Abiraterone—Cardiac disorder—Capecitabine—breast cancer	4.68e-05	0.000498	CcSEcCtD
Abiraterone—Dermatitis—Melphalan—breast cancer	4.68e-05	0.000498	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Fluorouracil—breast cancer	4.67e-05	0.000497	CcSEcCtD
Abiraterone—Cough—Paclitaxel—breast cancer	4.66e-05	0.000497	CcSEcCtD
Abiraterone—Asthenia—Vinorelbine—breast cancer	4.65e-05	0.000496	CcSEcCtD
Abiraterone—Arrhythmia—Docetaxel—breast cancer	4.65e-05	0.000495	CcSEcCtD
Abiraterone—Dyspnoea—Gemcitabine—breast cancer	4.65e-05	0.000495	CcSEcCtD
Abiraterone—Insomnia—Fluorouracil—breast cancer	4.63e-05	0.000494	CcSEcCtD
Abiraterone—Hypokalaemia—Epirubicin—breast cancer	4.62e-05	0.000492	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Irinotecan—breast cancer	4.62e-05	0.000492	CcSEcCtD
Abiraterone—Hypertension—Paclitaxel—breast cancer	4.62e-05	0.000492	CcSEcCtD
Abiraterone—Fatigue—Mitoxantrone—breast cancer	4.61e-05	0.000491	CcSEcCtD
Abiraterone—Fatigue—Irinotecan—breast cancer	4.61e-05	0.000491	CcSEcCtD
Abiraterone—Vomiting—Goserelin—breast cancer	4.6e-05	0.000491	CcSEcCtD
Abiraterone—Constipation—Irinotecan—breast cancer	4.57e-05	0.000487	CcSEcCtD
Abiraterone—Constipation—Mitoxantrone—breast cancer	4.57e-05	0.000487	CcSEcCtD
Abiraterone—Angiopathy—Capecitabine—breast cancer	4.57e-05	0.000487	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Epirubicin—breast cancer	4.57e-05	0.000487	CcSEcCtD
Abiraterone—Dyspnoea—Fluorouracil—breast cancer	4.57e-05	0.000487	CcSEcCtD
Abiraterone—Rash—Goserelin—breast cancer	4.57e-05	0.000487	CcSEcCtD
Abiraterone—Dermatitis—Goserelin—breast cancer	4.56e-05	0.000486	CcSEcCtD
Abiraterone—Mental disorder—Docetaxel—breast cancer	4.56e-05	0.000486	CcSEcCtD
Abiraterone—Chest pain—Paclitaxel—breast cancer	4.55e-05	0.000485	CcSEcCtD
Abiraterone—Myalgia—Paclitaxel—breast cancer	4.55e-05	0.000485	CcSEcCtD
Abiraterone—Mediastinal disorder—Capecitabine—breast cancer	4.54e-05	0.000484	CcSEcCtD
Abiraterone—Nasopharyngitis—Epirubicin—breast cancer	4.54e-05	0.000483	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	4.52e-05	0.000482	CcSEcCtD
Abiraterone—Dyspepsia—Fluorouracil—breast cancer	4.51e-05	0.000481	CcSEcCtD
Abiraterone—Arrhythmia—Capecitabine—breast cancer	4.5e-05	0.00048	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Gemcitabine—breast cancer	4.5e-05	0.000479	CcSEcCtD
Abiraterone—Discomfort—Paclitaxel—breast cancer	4.5e-05	0.000479	CcSEcCtD
Abiraterone—Fatigue—Gemcitabine—breast cancer	4.49e-05	0.000479	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Epirubicin—breast cancer	4.48e-05	0.000477	CcSEcCtD
Abiraterone—Constipation—Gemcitabine—breast cancer	4.46e-05	0.000475	CcSEcCtD
Abiraterone—Asthenia—Thiotepa—breast cancer	4.44e-05	0.000474	CcSEcCtD
Abiraterone—Diarrhoea—Vinorelbine—breast cancer	4.44e-05	0.000473	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Fluorouracil—breast cancer	4.42e-05	0.000471	CcSEcCtD
Abiraterone—Mental disorder—Capecitabine—breast cancer	4.41e-05	0.00047	CcSEcCtD
Abiraterone—Oedema—Paclitaxel—breast cancer	4.36e-05	0.000465	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Methotrexate—breast cancer	4.36e-05	0.000464	CcSEcCtD
Abiraterone—Infection—Paclitaxel—breast cancer	4.33e-05	0.000462	CcSEcCtD
Abiraterone—Hypokalaemia—Doxorubicin—breast cancer	4.27e-05	0.000455	CcSEcCtD
Abiraterone—Diarrhoea—Thiotepa—breast cancer	4.24e-05	0.000452	CcSEcCtD
Abiraterone—Skin disorder—Paclitaxel—breast cancer	4.24e-05	0.000451	CcSEcCtD
Abiraterone—Body temperature increased—Mitoxantrone—breast cancer	4.23e-05	0.000451	CcSEcCtD
Abiraterone—Body temperature increased—Irinotecan—breast cancer	4.23e-05	0.000451	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Doxorubicin—breast cancer	4.23e-05	0.00045	CcSEcCtD
Abiraterone—Pneumonia—Methotrexate—breast cancer	4.2e-05	0.000448	CcSEcCtD
Abiraterone—Nasopharyngitis—Doxorubicin—breast cancer	4.2e-05	0.000447	CcSEcCtD
Abiraterone—Anaemia—Docetaxel—breast cancer	4.19e-05	0.000446	CcSEcCtD
Abiraterone—Infestation NOS—Methotrexate—breast cancer	4.18e-05	0.000445	CcSEcCtD
Abiraterone—Infestation—Methotrexate—breast cancer	4.18e-05	0.000445	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Doxorubicin—breast cancer	4.14e-05	0.000441	CcSEcCtD
Abiraterone—Vomiting—Vinorelbine—breast cancer	4.12e-05	0.000439	CcSEcCtD
Abiraterone—Body temperature increased—Gemcitabine—breast cancer	4.12e-05	0.000439	CcSEcCtD
Abiraterone—Rash—Vinorelbine—breast cancer	4.09e-05	0.000436	CcSEcCtD
Abiraterone—Dermatitis—Vinorelbine—breast cancer	4.09e-05	0.000435	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Epirubicin—breast cancer	4.08e-05	0.000434	CcSEcCtD
Abiraterone—Anaemia—Capecitabine—breast cancer	4.05e-05	0.000432	CcSEcCtD
Abiraterone—Pollakiuria—Epirubicin—breast cancer	4.05e-05	0.000432	CcSEcCtD
Abiraterone—Body temperature increased—Fluorouracil—breast cancer	4.05e-05	0.000432	CcSEcCtD
Abiraterone—Haematuria—Methotrexate—breast cancer	3.98e-05	0.000425	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Paclitaxel—breast cancer	3.97e-05	0.000423	CcSEcCtD
Abiraterone—Hyperglycaemia—Epirubicin—breast cancer	3.96e-05	0.000422	CcSEcCtD
Abiraterone—Cough—Docetaxel—breast cancer	3.95e-05	0.000421	CcSEcCtD
Abiraterone—Insomnia—Paclitaxel—breast cancer	3.95e-05	0.00042	CcSEcCtD
Abiraterone—Vomiting—Thiotepa—breast cancer	3.94e-05	0.00042	CcSEcCtD
Abiraterone—Pneumonia—Epirubicin—breast cancer	3.93e-05	0.000419	CcSEcCtD
Abiraterone—Hypertension—Docetaxel—breast cancer	3.91e-05	0.000417	CcSEcCtD
Abiraterone—Infestation—Epirubicin—breast cancer	3.91e-05	0.000417	CcSEcCtD
Abiraterone—Infestation NOS—Epirubicin—breast cancer	3.91e-05	0.000417	CcSEcCtD
Abiraterone—Rash—Thiotepa—breast cancer	3.91e-05	0.000416	CcSEcCtD
Abiraterone—Dermatitis—Thiotepa—breast cancer	3.9e-05	0.000416	CcSEcCtD
Abiraterone—Dyspnoea—Paclitaxel—breast cancer	3.89e-05	0.000414	CcSEcCtD
Abiraterone—Chest pain—Docetaxel—breast cancer	3.86e-05	0.000411	CcSEcCtD
Abiraterone—Myalgia—Docetaxel—breast cancer	3.86e-05	0.000411	CcSEcCtD
Abiraterone—Dyspepsia—Paclitaxel—breast cancer	3.84e-05	0.000409	CcSEcCtD
Abiraterone—Asthenia—Mitoxantrone—breast cancer	3.84e-05	0.000409	CcSEcCtD
Abiraterone—Asthenia—Irinotecan—breast cancer	3.84e-05	0.000409	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	3.83e-05	0.000408	CcSEcCtD
Abiraterone—Cough—Capecitabine—breast cancer	3.83e-05	0.000408	CcSEcCtD
Abiraterone—Urinary tract infection—Epirubicin—breast cancer	3.8e-05	0.000405	CcSEcCtD
Abiraterone—Hypertension—Capecitabine—breast cancer	3.79e-05	0.000404	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Doxorubicin—breast cancer	3.77e-05	0.000402	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Paclitaxel—breast cancer	3.77e-05	0.000401	CcSEcCtD
Abiraterone—Fatigue—Paclitaxel—breast cancer	3.76e-05	0.000401	CcSEcCtD
Abiraterone—Pollakiuria—Doxorubicin—breast cancer	3.75e-05	0.000399	CcSEcCtD
Abiraterone—Asthenia—Gemcitabine—breast cancer	3.74e-05	0.000398	CcSEcCtD
Abiraterone—Myalgia—Capecitabine—breast cancer	3.73e-05	0.000398	CcSEcCtD
Abiraterone—Chest pain—Capecitabine—breast cancer	3.73e-05	0.000398	CcSEcCtD
Abiraterone—Constipation—Paclitaxel—breast cancer	3.73e-05	0.000397	CcSEcCtD
Abiraterone—Haematuria—Epirubicin—breast cancer	3.73e-05	0.000397	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	3.71e-05	0.000395	CcSEcCtD
Abiraterone—Urinary tract disorder—Methotrexate—breast cancer	3.7e-05	0.000395	CcSEcCtD
Abiraterone—Oedema—Docetaxel—breast cancer	3.7e-05	0.000394	CcSEcCtD
Abiraterone—Discomfort—Capecitabine—breast cancer	3.69e-05	0.000393	CcSEcCtD
Abiraterone—Urethral disorder—Methotrexate—breast cancer	3.68e-05	0.000392	CcSEcCtD
Abiraterone—Infection—Docetaxel—breast cancer	3.67e-05	0.000391	CcSEcCtD
Abiraterone—Hyperglycaemia—Doxorubicin—breast cancer	3.66e-05	0.00039	CcSEcCtD
Abiraterone—Diarrhoea—Irinotecan—breast cancer	3.66e-05	0.00039	CcSEcCtD
Abiraterone—Diarrhoea—Mitoxantrone—breast cancer	3.66e-05	0.00039	CcSEcCtD
Abiraterone—Pneumonia—Doxorubicin—breast cancer	3.64e-05	0.000388	CcSEcCtD
Abiraterone—Infestation NOS—Doxorubicin—breast cancer	3.62e-05	0.000386	CcSEcCtD
Abiraterone—Infestation—Doxorubicin—breast cancer	3.62e-05	0.000386	CcSEcCtD
Abiraterone—Skin disorder—Docetaxel—breast cancer	3.59e-05	0.000383	CcSEcCtD
Abiraterone—Oedema—Capecitabine—breast cancer	3.58e-05	0.000381	CcSEcCtD
Abiraterone—Diarrhoea—Gemcitabine—breast cancer	3.57e-05	0.00038	CcSEcCtD
Abiraterone—Infection—Capecitabine—breast cancer	3.56e-05	0.000379	CcSEcCtD
Abiraterone—Urinary tract infection—Doxorubicin—breast cancer	3.52e-05	0.000375	CcSEcCtD
Abiraterone—Diarrhoea—Fluorouracil—breast cancer	3.51e-05	0.000373	CcSEcCtD
Abiraterone—Cardiac disorder—Methotrexate—breast cancer	3.48e-05	0.000371	CcSEcCtD
Abiraterone—Skin disorder—Capecitabine—breast cancer	3.48e-05	0.000371	CcSEcCtD
Abiraterone—Urinary tract disorder—Epirubicin—breast cancer	3.47e-05	0.000369	CcSEcCtD
Abiraterone—Haematuria—Doxorubicin—breast cancer	3.45e-05	0.000368	CcSEcCtD
Abiraterone—Connective tissue disorder—Epirubicin—breast cancer	3.45e-05	0.000368	CcSEcCtD
Abiraterone—Body temperature increased—Paclitaxel—breast cancer	3.45e-05	0.000367	CcSEcCtD
Abiraterone—Urethral disorder—Epirubicin—breast cancer	3.44e-05	0.000367	CcSEcCtD
Abiraterone—Angiopathy—Methotrexate—breast cancer	3.4e-05	0.000363	CcSEcCtD
Abiraterone—Vomiting—Mitoxantrone—breast cancer	3.4e-05	0.000362	CcSEcCtD
Abiraterone—Vomiting—Irinotecan—breast cancer	3.4e-05	0.000362	CcSEcCtD
Abiraterone—Mediastinal disorder—Methotrexate—breast cancer	3.38e-05	0.00036	CcSEcCtD
Abiraterone—Rash—Irinotecan—breast cancer	3.37e-05	0.000359	CcSEcCtD
Abiraterone—Rash—Mitoxantrone—breast cancer	3.37e-05	0.000359	CcSEcCtD
Abiraterone—Dermatitis—Mitoxantrone—breast cancer	3.37e-05	0.000359	CcSEcCtD
Abiraterone—Dermatitis—Irinotecan—breast cancer	3.37e-05	0.000359	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Docetaxel—breast cancer	3.37e-05	0.000359	CcSEcCtD
Abiraterone—Insomnia—Docetaxel—breast cancer	3.34e-05	0.000356	CcSEcCtD
Abiraterone—Vomiting—Gemcitabine—breast cancer	3.31e-05	0.000353	CcSEcCtD
Abiraterone—Dyspnoea—Docetaxel—breast cancer	3.3e-05	0.000351	CcSEcCtD
Abiraterone—Mental disorder—Methotrexate—breast cancer	3.29e-05	0.00035	CcSEcCtD
Abiraterone—Rash—Gemcitabine—breast cancer	3.29e-05	0.00035	CcSEcCtD
Abiraterone—Dermatitis—Gemcitabine—breast cancer	3.28e-05	0.00035	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Capecitabine—breast cancer	3.26e-05	0.000348	CcSEcCtD
Abiraterone—Cardiac disorder—Epirubicin—breast cancer	3.26e-05	0.000347	CcSEcCtD
Abiraterone—Vomiting—Fluorouracil—breast cancer	3.26e-05	0.000347	CcSEcCtD
Abiraterone—Dyspepsia—Docetaxel—breast cancer	3.25e-05	0.000347	CcSEcCtD
Abiraterone—Insomnia—Capecitabine—breast cancer	3.24e-05	0.000345	CcSEcCtD
Abiraterone—Rash—Fluorouracil—breast cancer	3.23e-05	0.000344	CcSEcCtD
Abiraterone—Dermatitis—Fluorouracil—breast cancer	3.23e-05	0.000344	CcSEcCtD
Abiraterone—Urinary tract disorder—Doxorubicin—breast cancer	3.21e-05	0.000342	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Docetaxel—breast cancer	3.19e-05	0.00034	CcSEcCtD
Abiraterone—Connective tissue disorder—Doxorubicin—breast cancer	3.19e-05	0.00034	CcSEcCtD
Abiraterone—Dyspnoea—Capecitabine—breast cancer	3.19e-05	0.00034	CcSEcCtD
Abiraterone—Fatigue—Docetaxel—breast cancer	3.19e-05	0.00034	CcSEcCtD
Abiraterone—Angiopathy—Epirubicin—breast cancer	3.19e-05	0.000339	CcSEcCtD
Abiraterone—Urethral disorder—Doxorubicin—breast cancer	3.18e-05	0.000339	CcSEcCtD
Abiraterone—Mediastinal disorder—Epirubicin—breast cancer	3.16e-05	0.000337	CcSEcCtD
Abiraterone—Constipation—Docetaxel—breast cancer	3.16e-05	0.000337	CcSEcCtD
Abiraterone—Dyspepsia—Capecitabine—breast cancer	3.15e-05	0.000336	CcSEcCtD
Abiraterone—Arrhythmia—Epirubicin—breast cancer	3.14e-05	0.000334	CcSEcCtD
Abiraterone—Asthenia—Paclitaxel—breast cancer	3.13e-05	0.000333	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Capecitabine—breast cancer	3.09e-05	0.000329	CcSEcCtD
Abiraterone—Fatigue—Capecitabine—breast cancer	3.09e-05	0.000329	CcSEcCtD
Abiraterone—Mental disorder—Epirubicin—breast cancer	3.08e-05	0.000328	CcSEcCtD
Abiraterone—Constipation—Capecitabine—breast cancer	3.06e-05	0.000326	CcSEcCtD
Abiraterone—Anaemia—Methotrexate—breast cancer	3.02e-05	0.000322	CcSEcCtD
Abiraterone—Cardiac disorder—Doxorubicin—breast cancer	3.01e-05	0.000321	CcSEcCtD
Abiraterone—Diarrhoea—Paclitaxel—breast cancer	2.98e-05	0.000318	CcSEcCtD
Abiraterone—Angiopathy—Doxorubicin—breast cancer	2.95e-05	0.000314	CcSEcCtD
Abiraterone—Mediastinal disorder—Doxorubicin—breast cancer	2.93e-05	0.000312	CcSEcCtD
Abiraterone—Body temperature increased—Docetaxel—breast cancer	2.92e-05	0.000311	CcSEcCtD
Abiraterone—Arrhythmia—Doxorubicin—breast cancer	2.9e-05	0.000309	CcSEcCtD
Abiraterone—Cough—Methotrexate—breast cancer	2.85e-05	0.000304	CcSEcCtD
Abiraterone—Mental disorder—Doxorubicin—breast cancer	2.85e-05	0.000303	CcSEcCtD
Abiraterone—Body temperature increased—Capecitabine—breast cancer	2.83e-05	0.000302	CcSEcCtD
Abiraterone—Anaemia—Epirubicin—breast cancer	2.82e-05	0.000301	CcSEcCtD
Abiraterone—Myalgia—Methotrexate—breast cancer	2.78e-05	0.000296	CcSEcCtD
Abiraterone—Chest pain—Methotrexate—breast cancer	2.78e-05	0.000296	CcSEcCtD
Abiraterone—Vomiting—Paclitaxel—breast cancer	2.77e-05	0.000296	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.76e-05	0.000294	CcSEcCtD
Abiraterone—Rash—Paclitaxel—breast cancer	2.75e-05	0.000293	CcSEcCtD
Abiraterone—Dermatitis—Paclitaxel—breast cancer	2.75e-05	0.000293	CcSEcCtD
Abiraterone—Discomfort—Methotrexate—breast cancer	2.75e-05	0.000293	CcSEcCtD
Abiraterone—Cough—Epirubicin—breast cancer	2.67e-05	0.000284	CcSEcCtD
Abiraterone—Asthenia—Docetaxel—breast cancer	2.65e-05	0.000283	CcSEcCtD
Abiraterone—Infection—Methotrexate—breast cancer	2.65e-05	0.000282	CcSEcCtD
Abiraterone—Hypertension—Epirubicin—breast cancer	2.64e-05	0.000281	CcSEcCtD
Abiraterone—Anaemia—Doxorubicin—breast cancer	2.61e-05	0.000278	CcSEcCtD
Abiraterone—Chest pain—Epirubicin—breast cancer	2.6e-05	0.000277	CcSEcCtD
Abiraterone—Myalgia—Epirubicin—breast cancer	2.6e-05	0.000277	CcSEcCtD
Abiraterone—Skin disorder—Methotrexate—breast cancer	2.59e-05	0.000276	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.58e-05	0.000275	CcSEcCtD
Abiraterone—Discomfort—Epirubicin—breast cancer	2.57e-05	0.000274	CcSEcCtD
Abiraterone—Asthenia—Capecitabine—breast cancer	2.57e-05	0.000274	CcSEcCtD
Abiraterone—Diarrhoea—Docetaxel—breast cancer	2.53e-05	0.00027	CcSEcCtD
Abiraterone—Oedema—Epirubicin—breast cancer	2.49e-05	0.000266	CcSEcCtD
Abiraterone—Infection—Epirubicin—breast cancer	2.48e-05	0.000264	CcSEcCtD
Abiraterone—Cough—Doxorubicin—breast cancer	2.47e-05	0.000263	CcSEcCtD
Abiraterone—Diarrhoea—Capecitabine—breast cancer	2.45e-05	0.000261	CcSEcCtD
Abiraterone—Hypertension—Doxorubicin—breast cancer	2.44e-05	0.00026	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Methotrexate—breast cancer	2.43e-05	0.000259	CcSEcCtD
Abiraterone—Skin disorder—Epirubicin—breast cancer	2.42e-05	0.000258	CcSEcCtD
Abiraterone—Insomnia—Methotrexate—breast cancer	2.41e-05	0.000257	CcSEcCtD
Abiraterone—Chest pain—Doxorubicin—breast cancer	2.41e-05	0.000256	CcSEcCtD
Abiraterone—Myalgia—Doxorubicin—breast cancer	2.41e-05	0.000256	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.39e-05	0.000255	CcSEcCtD
Abiraterone—Discomfort—Doxorubicin—breast cancer	2.38e-05	0.000253	CcSEcCtD
Abiraterone—Dyspnoea—Methotrexate—breast cancer	2.38e-05	0.000253	CcSEcCtD
Abiraterone—Vomiting—Docetaxel—breast cancer	2.35e-05	0.000251	CcSEcCtD
Abiraterone—Dyspepsia—Methotrexate—breast cancer	2.35e-05	0.00025	CcSEcCtD
Abiraterone—Rash—Docetaxel—breast cancer	2.33e-05	0.000248	CcSEcCtD
Abiraterone—Dermatitis—Docetaxel—breast cancer	2.33e-05	0.000248	CcSEcCtD
Abiraterone—Oedema—Doxorubicin—breast cancer	2.31e-05	0.000246	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Methotrexate—breast cancer	2.3e-05	0.000245	CcSEcCtD
Abiraterone—Fatigue—Methotrexate—breast cancer	2.3e-05	0.000245	CcSEcCtD
Abiraterone—Infection—Doxorubicin—breast cancer	2.29e-05	0.000244	CcSEcCtD
Abiraterone—Vomiting—Capecitabine—breast cancer	2.28e-05	0.000243	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Epirubicin—breast cancer	2.27e-05	0.000242	CcSEcCtD
Abiraterone—Rash—Capecitabine—breast cancer	2.26e-05	0.000241	CcSEcCtD
Abiraterone—Insomnia—Epirubicin—breast cancer	2.26e-05	0.00024	CcSEcCtD
Abiraterone—Dermatitis—Capecitabine—breast cancer	2.26e-05	0.00024	CcSEcCtD
Abiraterone—Skin disorder—Doxorubicin—breast cancer	2.24e-05	0.000239	CcSEcCtD
Abiraterone—Dyspnoea—Epirubicin—breast cancer	2.22e-05	0.000237	CcSEcCtD
Abiraterone—Dyspepsia—Epirubicin—breast cancer	2.2e-05	0.000234	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Epirubicin—breast cancer	2.15e-05	0.000229	CcSEcCtD
Abiraterone—Fatigue—Epirubicin—breast cancer	2.15e-05	0.000229	CcSEcCtD
Abiraterone—Constipation—Epirubicin—breast cancer	2.13e-05	0.000227	CcSEcCtD
Abiraterone—Body temperature increased—Methotrexate—breast cancer	2.11e-05	0.000224	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.1e-05	0.000224	CcSEcCtD
Abiraterone—Insomnia—Doxorubicin—breast cancer	2.09e-05	0.000222	CcSEcCtD
Abiraterone—Dyspnoea—Doxorubicin—breast cancer	2.06e-05	0.000219	CcSEcCtD
Abiraterone—Dyspepsia—Doxorubicin—breast cancer	2.03e-05	0.000216	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Doxorubicin—breast cancer	1.99e-05	0.000212	CcSEcCtD
Abiraterone—Fatigue—Doxorubicin—breast cancer	1.99e-05	0.000212	CcSEcCtD
Abiraterone—Constipation—Doxorubicin—breast cancer	1.97e-05	0.00021	CcSEcCtD
Abiraterone—Body temperature increased—Epirubicin—breast cancer	1.97e-05	0.00021	CcSEcCtD
Abiraterone—Asthenia—Methotrexate—breast cancer	1.91e-05	0.000204	CcSEcCtD
Abiraterone—Body temperature increased—Doxorubicin—breast cancer	1.82e-05	0.000194	CcSEcCtD
Abiraterone—Diarrhoea—Methotrexate—breast cancer	1.82e-05	0.000194	CcSEcCtD
Abiraterone—Asthenia—Epirubicin—breast cancer	1.79e-05	0.000191	CcSEcCtD
Abiraterone—Diarrhoea—Epirubicin—breast cancer	1.71e-05	0.000182	CcSEcCtD
Abiraterone—Vomiting—Methotrexate—breast cancer	1.69e-05	0.000181	CcSEcCtD
Abiraterone—Rash—Methotrexate—breast cancer	1.68e-05	0.000179	CcSEcCtD
Abiraterone—Dermatitis—Methotrexate—breast cancer	1.68e-05	0.000179	CcSEcCtD
Abiraterone—Asthenia—Doxorubicin—breast cancer	1.66e-05	0.000176	CcSEcCtD
Abiraterone—Vomiting—Epirubicin—breast cancer	1.59e-05	0.000169	CcSEcCtD
Abiraterone—Diarrhoea—Doxorubicin—breast cancer	1.58e-05	0.000168	CcSEcCtD
Abiraterone—Rash—Epirubicin—breast cancer	1.57e-05	0.000168	CcSEcCtD
Abiraterone—Dermatitis—Epirubicin—breast cancer	1.57e-05	0.000167	CcSEcCtD
Abiraterone—Vomiting—Doxorubicin—breast cancer	1.47e-05	0.000156	CcSEcCtD
Abiraterone—Rash—Doxorubicin—breast cancer	1.46e-05	0.000155	CcSEcCtD
Abiraterone—Dermatitis—Doxorubicin—breast cancer	1.45e-05	0.000155	CcSEcCtD
Abiraterone—CYP2D6—Metabolism—ALDOA—breast cancer	2.79e-06	4.86e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP2D6—breast cancer	2.79e-06	4.85e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALDH1A1—breast cancer	2.79e-06	4.85e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALDH7A1—breast cancer	2.79e-06	4.85e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—RAF1—breast cancer	2.78e-06	4.84e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CD—breast cancer	2.77e-06	4.83e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.77e-06	4.83e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NCOA2—breast cancer	2.75e-06	4.79e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SERPINE1—breast cancer	2.74e-06	4.78e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NCOA2—breast cancer	2.74e-06	4.76e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CB—breast cancer	2.71e-06	4.72e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NCOA3—breast cancer	2.71e-06	4.71e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC2A2—breast cancer	2.69e-06	4.68e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—FHL2—breast cancer	2.67e-06	4.65e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—UMPS—breast cancer	2.67e-06	4.65e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ADSL—breast cancer	2.67e-06	4.65e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NME1—breast cancer	2.67e-06	4.65e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PHGDH—breast cancer	2.67e-06	4.65e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—FASN—breast cancer	2.67e-06	4.65e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—BCHE—breast cancer	2.66e-06	4.63e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—FASN—breast cancer	2.65e-06	4.62e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—BCHE—breast cancer	2.64e-06	4.6e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CG—breast cancer	2.64e-06	4.6e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ABCG2—breast cancer	2.63e-06	4.59e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CPT1A—breast cancer	2.63e-06	4.59e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—MTR—breast cancer	2.63e-06	4.59e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SLC5A5—breast cancer	2.63e-06	4.57e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HPSE—breast cancer	2.62e-06	4.56e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—LDHB—breast cancer	2.62e-06	4.56e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—BRIP1—breast cancer	2.62e-06	4.56e-05	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	2.62e-06	4.56e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NOS3—breast cancer	2.62e-06	4.56e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SLC5A5—breast cancer	2.61e-06	4.55e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HPGDS—breast cancer	2.58e-06	4.5e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HBA1—breast cancer	2.57e-06	4.47e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NQO1—breast cancer	2.54e-06	4.41e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SLC2A1—breast cancer	2.54e-06	4.41e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NQO1—breast cancer	2.52e-06	4.39e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SLC2A1—breast cancer	2.52e-06	4.39e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTT1—breast cancer	2.51e-06	4.36e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ACHE—breast cancer	2.51e-06	4.36e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IL2—breast cancer	2.49e-06	4.34e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MDM2—breast cancer	2.49e-06	4.33e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTA3—breast cancer	2.48e-06	4.32e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HMMR—breast cancer	2.48e-06	4.32e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCC1—breast cancer	2.48e-06	4.32e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.48e-06	4.32e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—RAF1—breast cancer	2.48e-06	4.31e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP3A4—breast cancer	2.47e-06	4.31e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.47e-06	4.3e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.46e-06	4.28e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP3A4—breast cancer	2.46e-06	4.28e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ERBB2—breast cancer	2.45e-06	4.27e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.45e-06	4.26e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP1B1—breast cancer	2.43e-06	4.23e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CB—breast cancer	2.42e-06	4.21e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MTOR—breast cancer	2.42e-06	4.21e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP1B1—breast cancer	2.42e-06	4.21e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CD4—breast cancer	2.41e-06	4.2e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PPARGC1B—breast cancer	2.41e-06	4.19e-05	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	2.4e-06	4.19e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTGS2—breast cancer	2.4e-06	4.17e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HSP90AA1—breast cancer	2.38e-06	4.15e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP17A1—breast cancer	2.37e-06	4.13e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HSP90AA1—breast cancer	2.37e-06	4.13e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ENO1—breast cancer	2.35e-06	4.09e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTGS1—breast cancer	2.35e-06	4.09e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CD—breast cancer	2.32e-06	4.04e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NCOA1—breast cancer	2.32e-06	4.04e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NCOA1—breast cancer	2.31e-06	4.01e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ALB—breast cancer	2.29e-06	3.99e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—STK11—breast cancer	2.29e-06	3.98e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP19A1—breast cancer	2.29e-06	3.98e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—STK11—breast cancer	2.27e-06	3.96e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP19A1—breast cancer	2.27e-06	3.96e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CA9—breast cancer	2.27e-06	3.96e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTA4—breast cancer	2.27e-06	3.96e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN1B—breast cancer	2.27e-06	3.95e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NCOA2—breast cancer	2.26e-06	3.93e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTA2—breast cancer	2.21e-06	3.85e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GPX2—breast cancer	2.21e-06	3.85e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—NOS3—breast cancer	2.19e-06	3.82e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—FASN—breast cancer	2.19e-06	3.82e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GPX4—breast cancer	2.19e-06	3.81e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SULT1A1—breast cancer	2.19e-06	3.81e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—BCHE—breast cancer	2.18e-06	3.8e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SRC—breast cancer	2.17e-06	3.78e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC5A5—breast cancer	2.16e-06	3.75e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.15e-06	3.74e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CTNNB1—breast cancer	2.14e-06	3.73e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTA1—breast cancer	2.14e-06	3.72e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—IDH1—breast cancer	2.14e-06	3.72e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.13e-06	3.71e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—COMT—breast cancer	2.13e-06	3.7e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—VEGFA—breast cancer	2.12e-06	3.69e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTP1—breast cancer	2.12e-06	3.68e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—COMT—breast cancer	2.11e-06	3.68e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NAT2—breast cancer	2.11e-06	3.68e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTP1—breast cancer	2.1e-06	3.66e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN1A—breast cancer	2.09e-06	3.65e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTEN—breast cancer	2.09e-06	3.64e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HMOX1—breast cancer	2.09e-06	3.63e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC2A1—breast cancer	2.08e-06	3.62e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NQO1—breast cancer	2.08e-06	3.62e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ITPR1—breast cancer	2.08e-06	3.62e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HMOX1—breast cancer	2.07e-06	3.61e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ITPR1—breast cancer	2.07e-06	3.6e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CA—breast cancer	2.05e-06	3.56e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP3A4—breast cancer	2.03e-06	3.53e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CB—breast cancer	2.03e-06	3.53e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTGS2—breast cancer	2.01e-06	3.49e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MAPK3—breast cancer	2e-06	3.49e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ABCB1—breast cancer	2e-06	3.49e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP1B1—breast cancer	2e-06	3.47e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ABCB1—breast cancer	1.99e-06	3.47e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—TYMS—breast cancer	1.97e-06	3.42e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HSP90AA1—breast cancer	1.96e-06	3.41e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—TYMS—breast cancer	1.96e-06	3.4e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PLA2G4A—breast cancer	1.94e-06	3.38e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NCOR1—breast cancer	1.94e-06	3.38e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTM1—breast cancer	1.94e-06	3.38e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TGFB1—breast cancer	1.94e-06	3.38e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SRC—breast cancer	1.94e-06	3.37e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTM1—breast cancer	1.93e-06	3.36e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PLA2G4A—breast cancer	1.93e-06	3.36e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NCOR1—breast cancer	1.93e-06	3.36e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NCOA1—breast cancer	1.9e-06	3.31e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—STK11—breast cancer	1.88e-06	3.27e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP19A1—breast cancer	1.88e-06	3.27e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—STAT3—breast cancer	1.87e-06	3.25e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GPX1—breast cancer	1.86e-06	3.24e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MED12—breast cancer	1.85e-06	3.22e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—DPYD—breast cancer	1.85e-06	3.22e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GPX1—breast cancer	1.85e-06	3.22e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP1A1—breast cancer	1.84e-06	3.21e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP1A1—breast cancer	1.83e-06	3.19e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ERCC2—breast cancer	1.83e-06	3.18e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALDOA—breast cancer	1.82e-06	3.17e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ERCC2—breast cancer	1.82e-06	3.16e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—KRAS—breast cancer	1.8e-06	3.13e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MAPK3—breast cancer	1.79e-06	3.11e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NCOA3—breast cancer	1.77e-06	3.08e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC2A2—breast cancer	1.76e-06	3.06e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTEN—breast cancer	1.75e-06	3.05e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—COMT—breast cancer	1.74e-06	3.04e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MYC—breast cancer	1.74e-06	3.02e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTP1—breast cancer	1.74e-06	3.02e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TGFB1—breast cancer	1.73e-06	3.02e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCG2—breast cancer	1.72e-06	3e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CPT1A—breast cancer	1.72e-06	3e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MTR—breast cancer	1.72e-06	3e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—MTHFR—breast cancer	1.72e-06	2.99e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HMOX1—breast cancer	1.71e-06	2.98e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ITPR1—breast cancer	1.71e-06	2.97e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—MTHFR—breast cancer	1.71e-06	2.97e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—EGFR—breast cancer	1.7e-06	2.96e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HPGDS—breast cancer	1.69e-06	2.94e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HBA1—breast cancer	1.68e-06	2.92e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—AKT1—breast cancer	1.67e-06	2.91e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CA—breast cancer	1.65e-06	2.88e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ABCB1—breast cancer	1.64e-06	2.86e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTT1—breast cancer	1.64e-06	2.85e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ACHE—breast cancer	1.64e-06	2.85e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—TYMS—breast cancer	1.61e-06	2.81e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—KRAS—breast cancer	1.6e-06	2.79e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TP53—breast cancer	1.6e-06	2.78e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTM1—breast cancer	1.6e-06	2.78e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NCOR1—breast cancer	1.6e-06	2.78e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.6e-06	2.78e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CAV1—breast cancer	1.58e-06	2.76e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CAV1—breast cancer	1.58e-06	2.74e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP17A1—breast cancer	1.55e-06	2.7e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ENO1—breast cancer	1.53e-06	2.67e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTGS1—breast cancer	1.53e-06	2.67e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—HRAS—breast cancer	1.53e-06	2.66e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GPX1—breast cancer	1.53e-06	2.66e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.51e-06	2.64e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP1A1—breast cancer	1.51e-06	2.63e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.51e-06	2.62e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP2D6—breast cancer	1.51e-06	2.62e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ERCC2—breast cancer	1.5e-06	2.61e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NCOA2—breast cancer	1.48e-06	2.57e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CA—breast cancer	1.47e-06	2.57e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CG—breast cancer	1.44e-06	2.51e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CG—breast cancer	1.44e-06	2.5e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—FASN—breast cancer	1.43e-06	2.49e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—BCHE—breast cancer	1.43e-06	2.48e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—MTHFR—breast cancer	1.41e-06	2.46e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC5A5—breast cancer	1.41e-06	2.45e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HRAS—breast cancer	1.36e-06	2.37e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC2A1—breast cancer	1.36e-06	2.37e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NQO1—breast cancer	1.36e-06	2.37e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—AKT1—breast cancer	1.35e-06	2.35e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IL6—breast cancer	1.31e-06	2.27e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP1B1—breast cancer	1.31e-06	2.27e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CAV1—breast cancer	1.3e-06	2.26e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.28e-06	2.23e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CD—breast cancer	1.27e-06	2.21e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CD—breast cancer	1.26e-06	2.2e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALB—breast cancer	1.25e-06	2.18e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NCOA1—breast cancer	1.25e-06	2.17e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CA—breast cancer	1.23e-06	2.15e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP19A1—breast cancer	1.23e-06	2.14e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—STK11—breast cancer	1.23e-06	2.14e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKT1—breast cancer	1.2e-06	2.1e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NOS3—breast cancer	1.2e-06	2.09e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NOS3—breast cancer	1.19e-06	2.07e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CG—breast cancer	1.19e-06	2.06e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—COMT—breast cancer	1.14e-06	1.99e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTP1—breast cancer	1.14e-06	1.98e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HMOX1—breast cancer	1.12e-06	1.95e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ITPR1—breast cancer	1.12e-06	1.94e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CB—breast cancer	1.11e-06	1.93e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CB—breast cancer	1.1e-06	1.91e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTGS2—breast cancer	1.1e-06	1.91e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTGS2—breast cancer	1.09e-06	1.9e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCB1—breast cancer	1.07e-06	1.87e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TYMS—breast cancer	1.06e-06	1.84e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.04e-06	1.82e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NCOR1—breast cancer	1.04e-06	1.82e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTM1—breast cancer	1.04e-06	1.82e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CD—breast cancer	1.04e-06	1.81e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALB—breast cancer	1.03e-06	1.79e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AKT1—breast cancer	1.01e-06	1.76e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GPX1—breast cancer	9.99e-07	1.74e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP1A1—breast cancer	9.89e-07	1.72e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NOS3—breast cancer	9.84e-07	1.71e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ERCC2—breast cancer	9.81e-07	1.71e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTEN—breast cancer	9.56e-07	1.66e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTEN—breast cancer	9.5e-07	1.65e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MTHFR—breast cancer	9.22e-07	1.61e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CB—breast cancer	9.08e-07	1.58e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTGS2—breast cancer	9e-07	1.57e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CAV1—breast cancer	8.51e-07	1.48e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTEN—breast cancer	7.85e-07	1.37e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CG—breast cancer	7.75e-07	1.35e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CD—breast cancer	6.81e-07	1.19e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CA—breast cancer	6.74e-07	1.17e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALB—breast cancer	6.72e-07	1.17e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CA—breast cancer	6.7e-07	1.17e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NOS3—breast cancer	6.43e-07	1.12e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CB—breast cancer	5.94e-07	1.03e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTGS2—breast cancer	5.88e-07	1.02e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CA—breast cancer	5.54e-07	9.64e-06	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKT1—breast cancer	5.51e-07	9.59e-06	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKT1—breast cancer	5.48e-07	9.53e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTEN—breast cancer	5.13e-07	8.93e-06	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKT1—breast cancer	4.52e-07	7.87e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CA—breast cancer	3.62e-07	6.3e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKT1—breast cancer	2.96e-07	5.15e-06	CbGpPWpGaD
